Anavex Life Sciences Corp.
IPOAnavex Life Sciences | Advancing Therapies for Alzheimer’s and Parkinson's Disease, Parkinson’s Disease
Public · United States · $50.0M raised
- Business Model
- B2B
- Website
- anavex.com
- Total Funding
- $50.0M
- Last Round
- $50.0M Venture RoundOct 2019
- Rounds
- 1
- Type
- Public
About
Anavex Life Sciences (Nasdaq: AVXL) is a biopharmaceutical company developing CNS therapies for Alzheimer's and Parkinson's disease.
Summary
Anavex Life Sciences Corp. is a Biotech company based in United States. It has raised $50.0M in total across 1 round, most recently a $50.0M Venture Round round in Oct 2019. Investors include Lincoln Park Capital.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Oct 2019
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...